95 related articles for article (PubMed ID: 10328518)
1. The clinical significance of ganciclovir resistance in a renal transplant patient.
Aitken C; Barrett-Muir W; Raftery M; Breuer J
Nephrol Dial Transplant; 1999 Apr; 14(4):1050-1. PubMed ID: 10328518
[No Abstract] [Full Text] [Related]
2. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants.
Limaye AP; Corey L; Koelle DM; Davis CL; Boeckh M
Lancet; 2000 Aug; 356(9230):645-9. PubMed ID: 10968438
[TBL] [Abstract][Full Text] [Related]
3. Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
Hantz S; Michel D; Fillet AM; Guigonis V; Champier G; Mazeron MC; Bensman A; Denis F; Mertens T; Dehee A; Alain S
Antimicrob Agents Chemother; 2005 Apr; 49(4):1580-3. PubMed ID: 15793144
[TBL] [Abstract][Full Text] [Related]
4. A new mutation in the human cytomegalovirus UL97 gene may confer ganciclovir resistance in Chinese kidney transplant recipients.
Zhang Y; Zhao Z; Sun J; Cao G; Zhao F; Hu J; Liu L; Ji Y
Arch Virol; 2013 Jan; 158(1):247-50. PubMed ID: 23011309
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
6. [Strains of ganciclovir-resistant cytomegalovirus].
Calicó I; García E; Cortés A; Gavaldá J; Roman A; Valle I
Enferm Infecc Microbiol Clin; 1999; 17(7):330-4. PubMed ID: 10535184
[TBL] [Abstract][Full Text] [Related]
7. [Disease by CMV resistant to Ganciclovir. Should plasma valganciclovir levels be monitored in high risk patients?].
Sola E; Vega E; Gutiérrez C; López V; Cabello M; Burgos D; González Molina M; Siles J
Nefrologia; 2009; 29(2):180-1. PubMed ID: 19396331
[No Abstract] [Full Text] [Related]
8. Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection.
Alain S; Hantz S; Scieux C; Karras A; Mazeron MC; Szelag JC; Imbert BM; Fillet AM; Gouarin S; Mengelle C; De Wilde A; Cogne N; Champier G; Rogez S; Legendre C; Denis F
J Med Virol; 2004 Aug; 73(4):566-73. PubMed ID: 15221901
[TBL] [Abstract][Full Text] [Related]
9. Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.
West P; Schmiedeskamp M; Neeley H; Oberholzer J; Benedetti E; Kaplan B
Transpl Infect Dis; 2008 Apr; 10(2):129-32. PubMed ID: 17605740
[TBL] [Abstract][Full Text] [Related]
10. Recurrent and persistent cytomegalovirus infection in a kidney recipient caused by the L595S mutation in UL97 phosphotransferase gene.
Peixoto M; Mascarenhas L; Cunha A; Dutra M; Miranda E; Silva I; Costa S; Galvão B; Cunha A
Antivir Ther; 2012; 17(3):585-8. PubMed ID: 22293247
[TBL] [Abstract][Full Text] [Related]
11. Molecular Analysis of Ganciclovir-Resistant Cytomegalovirus in Renal Transplant Recipients with High Viral Load.
Sohrabi M; Behzadian F; Hosseini SM; Lashini H
Arch Iran Med; 2016 Oct; 19(10):700-703. PubMed ID: 27743434
[TBL] [Abstract][Full Text] [Related]
12. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
[TBL] [Abstract][Full Text] [Related]
13. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease.
Chou S; Marousek G; Guentzel S; Follansbee SE; Poscher ME; Lalezari JP; Miner RC; Drew WL
J Infect Dis; 1997 Sep; 176(3):786-9. PubMed ID: 9291334
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive restriction analysis of the UL97 region allows early detection of ganciclovir-resistant human cytomegalovirus in an immunocompromised child.
Prix L; Hamprecht K; Holzhüter B; Handgretinger R; Klingebiel T; Jahn G
J Infect Dis; 1999 Aug; 180(2):491-5. PubMed ID: 10395867
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
Ahsan N; Holman MJ; Yang HC
Clin Transplant; 1997 Dec; 11(6):633-9. PubMed ID: 9408699
[TBL] [Abstract][Full Text] [Related]
16. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
Reddy AJ; Zaas AK; Hanson KE; Palmer SM
J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
[TBL] [Abstract][Full Text] [Related]
17. Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.
Myhre HA; Haug Dorenberg D; Kristiansen KI; Rollag H; Leivestad T; Asberg A; Hartmann A
Transplantation; 2011 Jul; 92(2):217-23. PubMed ID: 21685829
[TBL] [Abstract][Full Text] [Related]
18. Aciclovir selects for ganciclovir-cross-resistance of human cytomegalovirus in vitro that is only in part explained by known mutations in the UL97 protein.
Michel D; Höhn S; Haller T; Jun D; Mertens T
J Med Virol; 2001 Sep; 65(1):70-6. PubMed ID: 11505446
[TBL] [Abstract][Full Text] [Related]
19. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates.
Chou S; Guentzel S; Michels KR; Miner RC; Drew WL
J Infect Dis; 1995 Jul; 172(1):239-42. PubMed ID: 7797920
[TBL] [Abstract][Full Text] [Related]
20. Polyradiculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and genotypic characterization of sequential virus isolates.
Smith IL; Shinkai M; Freeman WR; Spector SA
J Infect Dis; 1996 Jun; 173(6):1481-4. PubMed ID: 8648225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
